North Bay police detective honoured for work promoting mental health - CTV News

The county at the center of Pennsylvania’s measles outbreak is at a clear disadvantage because, local officials say, it lacks its own health department and it will now get special assistance from the Centers for Disease Control and Prevention (CDC). As of Wednesday, Pennsylvania had confirmed 1,222 measles cases, up from 86 the week before. Six measles-associated deaths have also been confirmed by the state. The CDC announced on Thursday it would send a scientist – specifically, a “disease detective” – from the agency’s epidemic intelligence service to help tackle Pennsylvania’s growing outbreak. “CDC will continue working closely with Pennsylvania health officials to provide the expertise and support needed to respond to the outbreak and protect public health,” a CDC spokesperson told NBC News on Thursday. The spokesperson also added that the CDC director, Dr Erica Schwartz, recommends the MMR vaccine “as the most effective way to prevent measles and protect against infection”. The network also reported that in addition to the deployment of the “disease detective,” the CDC was releasing nearly $4m to aid the measles response efforts in Pennsylvania.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.